Method for separation and purification of human amniotic fluid stem cell
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- FIELD OPERATION BLOOD TRANSFUSION INST OF PLA SCI ACAD OF MILITARY
- Publication Date
- 2009-04-29
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a method for separating and purifying cells, in particular to a method for separating and purifying human amniotic fluid stem cells. Background technique
[0002] The research on human amniotic fluid-derived stem cells (hAFSCs) has gradually attracted attention in recent years. In 2003, In't Anker et al. confirmed that hAFSCs could be isolated and cultured from amniotic fluid in the second trimester (17-22 weeks), which opened up a new way to obtain adult stem cells, which aroused great interest and attention of researchers. Current research shows that hAFSCs not only have the biological characteristics of general adult stem cells, but also have good proliferation ability and multi-lineage differentiation potential, and can also express some marker molecules unique to totipotent stem cells such as SSEA-4 (stage-specific embyronic antigen-4). 4. Special stage embryonic antigen-4), Oct-4 and nanog, etc., indicating that hAFSCs a...